FDA Releases DTC Guidances; “Not The Last Word” On Ads, McClellan Says
Executive Summary
FDA's publication of three draft guidances on direct-to-consumer advertising is unlikely to relieve pressure on the agency to explain its approach to enforcement actions against drug manufacturers that repeatedly run false and misleading promotions
You may also be interested in...
PhRMA DTC Guideline Compliance Could Avert Plaintiff, DoJ Backlash – Troy
Responding to warning and untitled letters from FDA's Division of Drug Marketing, Advertising & Communications could help to shield firms in the event of product liability suits, according to former FDA Chief Counsel Daniel Troy
PhRMA DTC Guideline Compliance Could Avert Plaintiff, DoJ Backlash – Troy
Responding to warning and untitled letters from FDA's Division of Drug Marketing, Advertising & Communications could help to shield firms in the event of product liability suits, according to former FDA Chief Counsel Daniel Troy
Disease Awareness Ads, Not Ban On DTC, Is Best Marketing Path – Morris
A ban on direct-to-consumer advertising may have the unintended consequence of shifting marketing dollars into less transparent promotional vehicles, consultant Louis Morris said during a Pharmaceutical Marketing Partnerships Institute meeting in Philadelphia July 25